Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT03010475 | A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects | PHASE1 | COMPLETED | 41 | — | — | Jan 5, 2017 | Aug 9, 2017 | Dec 20, 2017 | 1 | United Kingdom |
Based on sampling between 0 and 12 hours
Based on sampling between 0 and 96 hours
| Arm | Type | Description |
|---|---|---|
| Furosemide/Rosuvastatin/SNAC/Semaglutide | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Furosemide | DRUG | Oral administration A total of three single doses. |
| Rosuvastatin | DRUG | Oral administration. A total of three single doses. |
| SNAC | DRUG | Oral administration. A total of five single doses. |
| Semaglutide | DRUG | Oral administration. Once daily. |
Inclusion Criteria: * Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial * Male or female, aged 18-65 years (both inclusive) at the time of ...